Table 3.

Characteristics of the 12 patients in survival analysis

Patient number	Gender	Age (year)	Tumor size (cm)	AFP (ng/ml)	TNM stage	Relative levels of specific subsets
						CD3+CD56+	CD3−CD56+	CD4+	CD8+	αβTCR+	γδTCR+	Suvival time (week)
1	Male	51	2.3	11	II	H	H	L	H	L	L	23
2	Male	78	10	3	III	H	L	L	H	H	H	39
3	Male	65	14	1,210	III	H	H	H	H	H	H	39
4	Male	57	1.2	3	I	H	H	H	L	L	H	19
5	Male	70	3	9	II	H	L	L	H	L	L	48
6	Male	57	2	12	I	H	H	L	L	L	L	40
7	Male	38	4.5	103	IV	L	H	L	H	L	H	28
8	Male	74	3.7	82	II	L	L	H	L	H	L	23
9	Female	49	4	5	II	L	L	H	L	H	H	2
10	Male	58	10	43	III	L	L	H	L	H	H	15
11	Female	65	6.5	2	II	L	H	H	L	L	L	34
12	Male	48	3	27	II	L	L	L	H	H	L	16

AFP α-fetoprotein, H high, L low